FAM22E Activators
FAM22E Activators are a diverse array of chemical compounds that indirectly enhance the functional activity of FAM22E through modulation of various cellular signaling pathways. Forskolin, 8-Bromo-cAMP, Isoproterenol, Sildenafil, IBMX, and Dibutyryl cAMP all work to increase the levels of cyclic AMP (cAMP) within the cell, which in turn activates protein kinase A (PKA). Once activated, PKA has the potential to phosphorylate FAM22E, leading to its enhanced functional activity. Similarly, Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), and Ionomycin raises intracellular calcium levels to activate calmodulin-dependent protein kinases; both of these pathways can lead to the phosphorylation and possible activation of FAM22E. Anisomycin, while primarily known as a protein synthesis inhibitor, also activates stress-activated protein kinases such as JNK, which might indirectly result in the phosphorylation and activation of FAM22E.
Additionally, Retinoic acid, by binding to nuclear receptors, has the capacity to alter gene expression patterns within a cell, potentially creating an environment that supports the enhancement of FAM22E's activity. Epigallocatechin gallate (EGCG) acts as a kinase inhibitor, potentially relieving FAM22E from inhibitory phosphorylation, thereby promoting its active state. Lastly, LY294002, by inhibiting the PI3K/Akt pathway, may shift cellular signaling dynamics in favor of pathways that upregulate FAM22E activity. Collectively, these FAM22E Activators work through a spectrum of biochemical mechanisms, including the alteration of kinase activity and cAMP signaling, to indirectly promote the enhanced activity of FAM22E without the need for direct binding or upregulation of its expression
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA acts as a potent activator of protein kinase C (PKC), which in turn phosphorylates serine and threonine residues on target proteins. PKC-mediated phosphorylation might enhance the activity of FAM22E by altering its conformation or interaction with other cellular components. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
As a stable analogue of cAMP, 8-Bromo-cAMP activates PKA, bypassing the adenylyl cyclase step. This activation could lead to the phosphorylation and subsequent activation of FAM22E. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. Elevated calcium can activate calcium-dependent protein kinases, such as calmodulin-dependent kinase, which could phosphorylate and thereby activate FAM22E. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that activates adenylyl cyclase through G protein-coupled receptors, increasing cAMP levels and subsequently activating PKA. PKA could then phosphorylate FAM22E, enhancing its activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, thereby increasing cellular levels of cAMP and cGMP and potentially leading to activation of PKA and PKG which, in turn, could phosphorylate and enhance the activity of FAM22E. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
This cAMP analogue is resistant to degradation by cellular phosphodiesterases, leading to sustained activation of PKA. PKA then might phosphorylate and activate FAM22E. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that also activates stress-activated protein kinases like JNK. Activation of these kinases could lead to indirect phosphorylation and enhancement of the activity of FAM22E. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid binds to nuclear receptors and modulates gene expression. Through the regulation of gene expression, it might alter the cellular context in a way that indirectly enhances the functional activity of FAM22E. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits several protein kinases and might free FAM22E from inhibitory phosphorylation, thereby enhancing its functional activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a potent inhibitor of the PI3K/Akt pathway. By inhibiting this pathway, it might shift the balance of cellular signaling in a way that indirectly enhances the functional activity of FAM22E. | ||||||